Storage and handling
Store in a cool, dry place. Keep container tightly closed.
Store in a cool, dry place. Keep container tightly closed.
Equi-Spectorant
Powder
Expectorant
For veterinary use only
Guaifenesin USP..............................2 g (7% w/w)
In a base of sucrose, potassium iodide, ammonium chloride, artificial coloring and flavoring.
For horses only. Not for human use. Do not administer to lactating mares.
A palatable powder used as an expectorant in horses.
1 teaspoon per 250 lb. body weight orally in feed or via dose syringe.
Adult Horses: Not to exceed 1/2 oz. twice daily or as directed by your veterinarian.
Foals and Ponies: Consult your veterinarian.
For best results, horse should receive medication for 3-4 days.
Store in a cool, dry place. Keep container tightly closed.
Questions? Call 859-254-1221 or toll-free at 800-621-8829.
NDC: 13985-886-74
VETone®
Equi-Spectorant
Powder
Expectorant
For veterinary use only.
Keep out of reach of children.
Net Contents: 1 lb (454g)
V1 510053
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GUAIFENESIN | ACTIVE INGREDIENT | 495W7451VQ | 2 | |
| GUAIFENESIN | ACTIVE MOIETY | 495W7451VQ | 2 | |
| AMMONIUM CHLORIDE | INACTIVE INGREDIENT | 01Q9PC255D | 2 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 13985-886 | 13985-886-74 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| AMMONIUM CHLORIDE | 01Q9PC255D | IACT |
| GUAIFENESIN | 495W7451VQ | ACTIB |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| AMMONIUM CHLORIDE | AMMONIUM CHLORIDE | 01Q9PC255D | TABLET / ORAL | 8 mg | ||
| AMMONIUM CHLORIDE | AMMONIUM CHLORIDE | 01Q9PC255D | TABLET, FILM COATED / ORAL | 8 mg | ||
| AMMONIUM CHLORIDE | AMMONIUM CHLORIDE | 01Q9PC255D | SYRUP / ORAL | 131.68 mg/5ml | ||
| AMMONIUM CHLORIDE | AMMONIUM CHLORIDE | 01Q9PC255D | TABLET, EXTENDED RELEASE / ORAL | 21 mg | ||
| AMMONIUM CHLORIDE | AMMONIUM CHLORIDE | 01Q9PC255D | CAPSULE / ORAL | 8 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Ammonium muriaticum | AMMONIUM CHLORIDE | Boiron | 687eae27-d686-1a0f-e053-2a91aa0a124a | 2023-10-16 | AMMONIUM CHLORIDE | |
| Ammonium muriaticum | AMMONIUM CHLORIDE | Boiron | 84b58da5-40e4-f3c1-e053-2991aa0aeb82 | 2023-08-29 | AMMONIUM CHLORIDE | |
| Ammonium muriaticum | AMMONIUM CHLORIDE | Boiron | 8427af63-5644-be0c-e053-2a91aa0a255d | 2023-05-16 | AMMONIUM CHLORIDE |
Adverse event summaries are temporarily unavailable. Other product information remains available.